Camptothecin and mitomycin combination chemotherapy on ovarian clear cell carcinoma with multiple systemic metastases

被引：0
|
作者：
Tanaka, T [1 ]
Umesaki, N [1 ]
Ogita, S [1 ]
机构：
[1] Osaka City Univ, Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan
来源：
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2000年 / 21卷 / 04期
关键词：
camptothecin; mitomycin; clear cell carcinoma; ovary; chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ovarian clear cell carcinoma is known for decreased responsiveness to most anticancer drugs, and the prognosis of patients with ovarian clear cell tumors is very poor. We report such a patient with multiple systemic metastases who showed a complete response to combined camptothecin and mitomycin chemotherapy. During therapy, clinical drug-resistance was observed transiently, but response was restored by intermittent administrations of camptothecin. Such combination chemotherapy may be a useful alternative regimen for advanced and/or metastatic ovarian clear cell carcinoma.
引用
收藏
页码：377 / 379
页数：3
相关论文
共 50 条
  • [1] Impact of Combination Chemotherapy with Itraconazole on Survival for Patients with Recurrent or Persistent Ovarian Clear Cell Carcinoma
    Tsubamoto, Hiroshi
    Sonoda, Takashi
    Yamasaki, Masaaki
    Inoue, Kayo
    ANTICANCER RESEARCH, 2014, 34 (04) : 2007 - 2014
  • [2] Bilateral ovarian metastases from renal clear cell carcinoma
    Acta Oncol, 4 (379):
  • [3] Bilateral ovarian metastases from renal clear cell carcinoma
    Vara, A
    Madrigal, B
    Veiga, M
    Diaz, A
    García, J
    Calvo, J
    ACTA ONCOLOGICA, 1998, 37 (04) : 379 - 380
  • [4] Multiple metastases of renal clear cell carcinoma to the organs of the head
    Sawicki, Piotr
    Kazmierczak, Wojciech
    Burduk, Pawel
    Kazmierczak, Henryk
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (06): : 448 - 451
  • [5] Is adjuvant chemotherapy necessary for stage IA ovarian clear cell carcinoma?
    Mizuno, M.
    Kajiyama, H.
    Yamada, E.
    Matsumura, H.
    Kikkawa, F.
    14TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2011, : 251 - 254
  • [6] Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
    McNamara, Blair
    Bellone, Stefania
    Demirkiran, Cem
    Hartwich, Tobias Max Philipp
    Santin, Alessandro D.
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 48
  • [7] Specific issues in the systemic treatment strategy for ovarian clear cell carcinoma
    Kfoury, M.
    Tan, D.
    ESMO OPEN, 2024, 9 (04)
  • [8] Clear clinical remission of a diffuse metastasized ovarian clear cell carcinoma with third line chemotherapy
    Debois, JM
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (07) : 709 - 712
  • [9] COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C AND CISPLATIN FOR ADVANCED GASTRIC-CANCER WITH MULTIPLE LIVER METASTASES
    SAIKAWA, Y
    KUBOTA, T
    FURUKAWA, T
    KUMAI, K
    YOSHINO, K
    ISHIBIKI, K
    KITAJIMA, M
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (09): : 819 - 822
  • [10] COMBINATION CHEMOTHERAPY OF OVARIAN-CARCINOMA
    MYERS, RA
    BELINSON, J
    YATES, JW
    KRAKOFF, IH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 405 - 405
12345